GLP-1 Compounding: Legal, Regulatory, and Business Intelligence Hub
With GLP-1 medications like semaglutide and tirzepatide now widely used for weight loss management, the legal, regulatory, and business challenges surrounding their use, particularly in 503A compounding, have become increasingly complex. Frier Levitt attorneys are at the forefront of this evolving landscape, providing critical insights for pharmacies, prescribers, and other stakeholders navigating this dynamic landscape.
This resource hub features our latest webinars and articles covering FDA guidance, reimbursement strategies, payer trends, state board enforcement, litigation risks, and compliance strategies to help you stay informed and compliant amid rapidly evolving developments in the GLP-1 space.
Recent Articles
The Return of 503B Compounding of GLP-1 Medications
Over the last two years, the surging demand for GLP-1 receptor agonists such as semaglutide (Ozempic®, Wegovy®) and tirzepatide (Mounjaro®, Zepbound™) has created both clinical…
October 23, 2025
FDA Issues Import Alert on GLP-1s Following Launch of “Green List”
On September 19, 2025, the FDA issued Import Alert 66-80, which authorizes field staff to detain without physical examination shipments of GLP-1 active pharmaceutical ingredients…
October 1, 2025
Thea GLP-1 Crossroads: What Pharmacies Must Know About Compliance, Coverage, and the Future of Access
The surge of GLP-1 medications, from semaglutide products – such as Ozempic® and Wegovy® – to new therapies in the pipeline, has created one of…
September 4, 2025
Recent Webinars
“Navigating GLP-1 Compounding” Webinar Series
Stay ahead of the curve with our webinar series navigating the evolving regulatory landscape for GLP-1 compounding. Complete the form below to access these webinars:…
January 21, 2025
On-Demand Access: Mastering GLP-1 Compounding Series Q&A Roundup
Frier Levitt’s healthcare and pharmacy law attorneys present a follow-up webinar “Mastering GLP-1 Compounding Series Q&A Roundup,” where they tackle key issues based on the…
September 13, 2024
“Mastering GLP-1 Compounding,” a Comprehensive 3-Part Webinar Series Tailored for Pharmacy Professionals (On-Demand Access)
Stay ahead in 2025: Discover what’s on the horizon for GLP-1 compounding as we navigate evolving FDA guidelines and state Boards of Pharmacy regulations. Don’t…
July 23, 2024
